相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Relationship between pneumonia and cardiovascular diseases: A retrospective cohort study of the general population
Jun-Jun Yeh et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2019)
Adult vaccination for pneumococcal disease: a comparison of the national guidelines in Europe
C. Bonnave et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2019)
Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults
Allison Thompson et al.
VACCINE (2019)
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults
Helen L. Stacey et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Invasive Pneumococcal Disease Surveillance, 1 January to 31 March 2019
Rachael Corvisy et al.
COMMUNICABLE DISEASES INTELLIGENCE (2019)
Vaccines to Prevent Pneumococcal Community - Acquired Pneumonia
Cornelis H. van Werkhoven et al.
CLINICS IN CHEST MEDICINE (2018)
Pneumococcal vaccination in older persons: where are we today?
Paul Van Buynder et al.
PNEUMONIA (2018)
Long-term Impact of a 3+0 Schedule for 7-and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014
Sanjay Jayasinghe et al.
CLINICAL INFECTIOUS DISEASES (2017)
Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis
Tinevimbo Shiri et al.
LANCET GLOBAL HEALTH (2017)
Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review
Cornelius Remschmidt et al.
BMC INFECTIOUS DISEASES (2016)
Background paper to the updated pneumococcal vaccination recommendation for older adults in Germany
G. Falkenhorst et al.
BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ (2016)
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
M. J. M. Bonten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease
Antoni Torres et al.
THORAX (2015)
Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines
Tamara Pilishvili et al.
VACCINE (2015)
Impact of pneumococcal polysaccharide vaccine in people aged 65 years or older
Robert I. Menzies et al.
MEDICAL JOURNAL OF AUSTRALIA (2014)
Surveillance of pneumococcal serotype 1 carriage during an outbreak of serotype 1 invasive pneumococcal disease in central Australia 2010-2012
Jana Y. R. Lai et al.
BMC INFECTIOUS DISEASES (2013)
Risk of pneumonia and pneumococcal disease in people hospitalized with diabetes mellitus: English record-linkage studies
O. O. Seminog et al.
DIABETIC MEDICINE (2013)
Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
Daniel R. Feikin et al.
PLOS MEDICINE (2013)
分享论文
